PACS Group (NYSE:PACS) Stock: Insider Jason Hulse Murray Sells 26,504 Shares

PACS Group, Inc. (NYSE:PACS) CEO Jason Murray sold 26,504 shares of the business’s stock in a transaction that occurred on Tuesday, November 3rd. The shares were sold at an average price of $46.50, for a total value of $1,232,436.00. Following the sale, the chief executive officer owned 54,121,535 shares in the company, valued at approximately $2,516,651,377.50. This represents a 0.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

• On Wednesday, November 4th, Jason Murray sold 167,434 shares of PACS Group stock. The shares were sold at an average price of $50.24, for a total value of $8,411,884.16.
• On Monday, November 2nd, Jason Murray sold 31,358 shares of PACS Group stock. The stock was sold at an average price of $46.02, for a total value of $1,443,095.16.
• On Thursday, October 29th, Jason Murray sold 1,904 shares of PACS Group stock. The stock was sold at an average price of $50.05, for a total transaction of $95,295.20.
• On Wednesday, October 28th, Jason Murray sold 6,899 shares of PACS Group stock. The stock was sold at an average price of $50.10, for a total transaction of $345,639.90.
• On Friday, October 23rd, Jason Murray sold 68,917 shares of PACS Group stock. The shares were sold at an average price of $48.60, for a total transaction of $3,349,366.20.
• On Thursday, October 22nd, Jason Murray sold 13,696 shares of PACS Group stock. The shares were sold at an average price of $47.55, for a total transaction of $651,244.80.
• On Wednesday, October 21st, Jason Murray sold 6,610 shares of PACS Group stock. The shares were sold at an average price of $47.62, for a total transaction of $314,768.20.
• On Tuesday, October 20th, Jason Murray sold 37,477 shares of PACS Group stock. The stock was sold at an average price of $47.65, for a total transaction of $1,785,779.05.
• On Monday, October 19th, Jason Murray sold 1,620 shares of PACS Group stock. The stock was sold at an average price of $47.57, for a total transaction of $77,063.40.
• On Friday, October 16th, Jason Murray sold 8,462 shares of PACS Group stock. The shares were sold at an average price of $47.61, for a total transaction of $402,875.82.

PACS Group Price Performance

NYSE PACS traded up $3.95 on Wednesday, reaching $50.63. The company’s stock had a trading volume of 1,790,293 shares, compared to its average volume of 895,995. PACS Group, Inc. has a 52 week low of $10.31 and a 52 week high of $51.68. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.21. The firm has a market cap of $8.01 billion, a PE ratio of 29.44, a price-to-earnings-growth ratio of 1.42 and a beta of -0.14. The business has a 50-day moving average price of $44.29 and a 200 day moving average price of $39.85.

PACS Group (NYSE:PACS) last announced its quarterly earnings results on Tuesday, November 3rd. The company reported $0.63 EPS for the quarter, topping analysts’ consensus estimates of $0.58 by $0.05. The firm had revenue of $1.50 billion during the quarter, compared to analysts’ expectations of $1.46 billion. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. Sell-side analysts expect that PACS Group, Inc. will post 2.13 EPS for the current year.

Analyst Upgrades and Downgrades

PACS has been the subject of several analyst reports. Oppenheimer raised their target price on PACS Group from $48.00 to $57.00 and gave the stock an “outperform” rating in a research report on Monday, August 10th. Royal Bank Of Canada upped their price target on PACS Group from $52.00 to $57.00 and gave the company an “outperform” rating in a research report on Thursday, August 6th. Truist Financial set a $62.00 price target on PACS Group in a research report on Wednesday, September 2nd. Zacks Research lowered PACS Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 9th. Finally, Wall Street Zen cut PACS Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 8th. Five analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $58.80.

Institutional Trading of PACS Group

Several large investors have recently added to or reduced their stakes in PACS. Dimensional Fund Advisors LP increased its holdings in shares of PACS Group by 370.2% during the first quarter. Dimensional Fund Advisors LP now owns 780,159 shares of the company’s stock worth $25,051,000 after buying an additional 614,250 shares in the last quarter. Sei Investments Co. raised its stake in shares of PACS Group by 7.4% in the first quarter. Sei Investments Co. now owns 370,501 shares of the company’s stock valued at $11,900,000 after acquiring an additional 25,462 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in shares of PACS Group by 44.6% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 288,718 shares of the company’s stock worth $9,274,000 after acquiring an additional 89,067 shares in the last quarter. Bank of New York Mellon Corp acquired a new position in shares of PACS Group in the 2nd quarter worth approximately $8,196,000. Finally, Corient Private Wealth LP grew its position in PACS Group by 1.8% during the 2nd quarter. Corient Private Wealth LP now owns 152,846 shares of the company’s stock worth $6,517,000 after acquiring an additional 2,680 shares during the last quarter.

Key Headlines Impacting PACS Group

Here are the key news stories impacting PACS Group this week:

• Positive Sentiment: PACS reported third-quarter 2026 earnings of $0.63 per share, above estimates of $0.56–$0.58 and up from $0.32 a year earlier. Revenue of $1.50 billion also topped forecasts of $1.46 billion, supporting the positive market reaction. PACS Group, Inc. Reports Third Quarter 2026 Results PACS Group Q3 Earnings and Revenues Beat Estimates
• Negative Sentiment: CEO Jason Murray, director Mark Hancock, and chief accounting officer Michelle Lewis reported share sales. The sales could raise a modest concern about insider sentiment, but they were conducted under Rule 10b5-1 plans; Murray and Hancock continued to hold roughly 54 million shares each. CEO Form 4 filing Director Form 4 filing Chief accounting officer Form 4 filing

About PACS Group

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.